MaryTKorytkowskiMD

Diabetes, Lipid Metabolism

Professor of Medicine, University Pittsburgh

Dr. Korytkowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3601 5th Ave
# Falk
Pittsburgh, PA 15213
Phone+1 412-648-9577

Fax+1 412-586-9726

Dr. Mary Korytkowski is an endocrinologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Magee-Womens Hospital and UPMC Presbyterian. She received her medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 35 years. She specializes in diabetes and lipid metabolism.

Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1988
Sinai Hospital of BaltimoreFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1986
Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1982 - 1985
University of North Carolina at Chapel Hill School of MedicineClass of 1982

Pittsburgh Magazine Castle Connolly, 2005-2018
America's Top Doctors Castle Connolly, 2002-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Women's Health Castle Connolly, 2008
Top MD Consumers Checkbook
Diabetes Care Recognition Health Care Incentives Improvement Institute
Join now to see all

PubMed

Lectures

Update in Endocrinology
2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
Implications of Race for Coping with Newly Diagnosed Type 2 Diabetes
Pittsburgh, PA - 6/16/2014
Therapeutic Intensification Strategy and Incident Cardiovascular Disease (CVD) in Type 2 Diabetes Mellitus (T2DM)
Pittsburgh, PA - 6/16/2014
Transition from Pediatric to Adult Diabetes Care: Providers' Perceptions
Pittsburgh, PA - 6/15/2014
Factors Associated with Insulin Intensification Strategies in Uncontrolled Type 2 Diabetes (T2DM)
Pittsburgh, PA - 6/15/2014
Implementation of Glycemic Management Pathway after Bariatric Surgery: A Feasible and Efficacious Protocol
Pittsburgh, PA - 6/15/2014
Join now to see all

CGM Use, Education Focus of Managing Hyperglycemia in Hospitalized Adults with DiabetesJuly 19th, 2022
Endocrine Society Issues New Guidelines for Hospitalized Patients with DiabetesJune 13th, 2022
New Guideline for in-Hospital Care of Diabetes Says Use CGMsJune 13th, 2022
Join now to see all

Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d)National Center For Research Resources2005
Bypass Angioplasty Revascularization Investigation NIDDMNational Center For Research Resources2004
Insulin Hpn &Regular Premix Ratio 50 &50 VS Premix Ratios 70 &30National Center For Research Resources1999–2002
Sex Hormones As Risk Factors For Heart Disease In Women With NIDDMNational Center For Research Resources1997
Hyperandrogenism As A Risk Factor For Atherogenesis In Women With NIDDMNational Center For Research Resources1996–1997
Random Multiple Dose Placebo-Controlled Study Of Ari-509 In Diabetic PatientsNational Center For Research Resources1996
Multicenter Placebo-Controlled Pilot Study Of MiglitolNational Center For Research Resources1996
Multicenter Double-Blind Parallel Placebo And Tripro-Amylin Dose FrequencyNational Center For Research Resources1996
Effect Of Acute And Prolonged Glimepiride Therapy On Insulin SecretionNational Center For Research Resources1996